Aerosol Society's Drug Delivery to the Lungs event is the premiere European conference for the presentation of lectures and posters relating to the development of inhalers for respiratory diseases
Three key members of early clinical phase solution provider Pharmaceutical Profiles's scientific team will be representing the company at the Aerosol Society's Drug Delivery to the Lungs event in Edinburgh, 7-9 December 2005.
Company founder and scientific advisor Steve Newman is giving a plenary session on 'In-vivo methods for the characterisation of inhalation products'.
Pharmaceutical Profiles's head of development, Gary Pitcairn, and Principal radio-labelling scientist, Matthew Pickford, are attending the event as delegates.
The Aerosol Society's Drug Delivery to the Lungs event is the premiere European conference for the presentation of lectures and posters relating to the development of inhalers for the treatment of both respiratory diseases and also for systemic drug delivery.
Also in December, chief operating officer Simon Lee is attending the GOR's (Global Outsourcing Review) pharmaceutical series of Asia-Pacific Technology seminars in London.
Both events will enable the company to showcase its unique range of products and drug delivery systems, cultivate existing clients and make new contacts.
